Keyphrases
Relative Effectiveness
100%
Invasive Lobular Carcinoma
100%
Adjuvant Chemotherapy
100%
Breast Invasive Ductal Carcinoma
100%
Invasive Ductal Carcinoma
85%
Endocrine Therapy
71%
Chemotherapy
57%
Patient Characteristics
28%
HER2-positive
28%
Confidence Interval
28%
Overall Survival
28%
Estrogen Receptor-positive
28%
Hazard Ratio
28%
Overall Survival Rate
28%
Breast Cancer Treatment
14%
Adverse Effects
14%
Clinical Characteristics
14%
Patient Treatment
14%
Patient Survival
14%
Clinical Genomics
14%
Patients with Breast Cancer
14%
Non-associated
14%
Economic Burden
14%
Patient Tumor
14%
Treatment Characteristics
14%
Receptor 1
14%
Relative Impact
14%
Tumor Characteristics
14%
Kaplan-Meier Method
14%
California Cancer Registry
14%
Pathologic Characteristics
14%
Genomic Characteristics
14%
Human Epidermal Growth Factor Receptor
14%
Cox Proportional Hazards Modeling
14%
Treatment Factors
14%
Medicine and Dentistry
Breast Carcinoma
100%
Lobular Carcinoma
100%
Adjuvant Chemotherapy
100%
Hormone Therapy
71%
Overall Survival
57%
Breast Cancer
28%
Hazard Ratio
28%
Survival Rate
28%
Estrogen Receptor
28%
Malignant Neoplasm
14%
Cancer Therapy
14%
Neoplasm
14%
Cancer Registry
14%
Gamma Urogastrone
14%
Kaplan Meier Method
14%
Epidermal Growth Factor Receptor
14%
Adverse Effect
14%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Breast Carcinoma
100%
Lobular Carcinoma
77%
Endocrine Therapy
55%
Overall Survival
44%
Estrogen Receptor
22%
Breast Cancer
22%
Survival Rate
22%
Cancer Registry
11%
Malignant Neoplasm
11%
Gamma Urogastrone
11%
Neoplasm
11%
Epidermal Growth Factor Receptor
11%